Drugs.com - Clinical Trials

NIH Researchers Discover Novel Class of Anti-Malaria Antibodies

January 3, 2025 -- A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study from researchers at the National Institutes of Health (NIH) published...

Feb 9, 2025 - 21:44
 0
NIH Researchers Discover Novel Class of Anti-Malaria Antibodies
January 3, 2025 -- A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study from researchers at the National Institutes of Health (NIH) published...
Read More

Tags:

Previous Article

Gradalis’ GRAD1405 bi-shRNAi Candidate First to Show Positive Impact on Three Ke...

Next Article

Axsome Therapeutics Announces Successful Completion and Results of Phase 3 Clini...

Related Posts

Lipella Pharmaceuticals Granted FDA Approval for Expanded Access Program for LP-310 in Oral Lichen Planus

Lipella Pharmaceuticals Granted FDA Approval for Expand...

Feb 9, 2025  0

BioRestorative Receives FDA Fast Track Designation for BRTX-100 Chronic Lumbar Disc Disease Program

BioRestorative Receives FDA Fast Track Designation for ...

Mar 1, 2025  0

Humanetics Corporation Announces Positive Phase 2 Clinical Trial Results in COVID-19 Study Aimed at Improving Pulmonary Function

Humanetics Corporation Announces Positive Phase 2 Clini...

Feb 9, 2025  0